Skip to main content

Durezol Side Effects

Generic name: difluprednate ophthalmic

Medically reviewed by Drugs.com. Last updated on Jun 23, 2023.

Note: This document contains side effect information about difluprednate ophthalmic. Some dosage forms listed on this page may not apply to the brand name Durezol.

Applies to difluprednate ophthalmic: ophthalmic emulsion.

Serious side effects of Durezol

Along with its needed effects, difluprednate ophthalmic (the active ingredient contained in Durezol) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking difluprednate ophthalmic:

More common

Less common

Other side effects of Durezol

Some side effects of difluprednate ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

Rare

For Healthcare Professionals

Applies to difluprednate ophthalmic: ophthalmic emulsion.

Ocular

Common (1% to 10%): Corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, blurred vision, eye irritation

Uncommon (0.1% to 1%): Corneal pigmentation and striae, episcleritis, eye pruritus, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, increased intraocular pressure, iritis, limbal and conjunctival hyperemia, dry eye, iridocyclitis[Ref]

General

The most commonly reported side effects were elevated intraocular pressure, visual acuity and field defects, and posterior subcapsular cataract formation.[Ref]

Local

Uncommon (0.1% to 1%): Application site discomfort or irritation[Ref]

Nervous system

Common (1% to 10%): Headache[Ref]

References

1. Product Information. Durezol (difluprednate ophthalmic). Sirion Therapeutics. 2008.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.